Creating Value Through Breakthrough Science

PlanetiQ, a leading provider of commercial weather and space weather data, has been awarded a $24.3 million contract from NOAA’s National Environmental Satellite, Data, and Information Service (NESDIS). The award, issued under the Commercial Data Program’s Radio Occultation Data Buy 2 (RODB-2), is NOAA’s single largest commercial satellite weather data

Paragraf, the UK-based company leading the way in mass-producing graphene-based electronics using industry-standard semiconductor processes, has completed a $55m Series C funding round. The funding will accelerate scaling of Paragraf’s manufacturing capabilities and boost production output to enable the adoption of graphene electronics in mass markets. Paragraf’s technology integrates seamlessly

Ferric, the leader in cutting-edge power conversion solutions, has announced the launch of its latest flagship product, Fe1766, an Integrated Voltage Regulator (IVR) that sets new standards in current delivery, power density, efficiency, and regulation bandwidth for the most power-hungry digital processors. Built to address power demands of AI processors,

VORAGO Technologies, a leader in radiation-hardened and extreme-temperature semiconductor solutions, has announced the upcoming availability of the VA5 family, a new generation of dual-core Arm® Cortex®-M55 microcontrollers engineered to meet the rigorous demands of aerospace, defense, and deep space missions. The family includes both radiation-hardened and radiation-tolerant variants—providing engineers the

Richardson Electronics, Ltd. (NASDAQ: RELL) has announced a global technology partner agreement with Pakal Technologies, Inc., a cutting-edge innovator in silicon power semiconductor solutions. Under this agreement, Richardson Electronics will partner with Pakal to supply customers with Pakal’s advanced 650V and 1200V silicon-based power switches—delivering breakthrough efficiency to customers worldwide. Pakal

Novadip Biosciences, a late-stage clinical biotechnology company specializing in regenerative medicine, and the Cliniques universitaires Saint-Luc have announced the successful treatment of four pediatric patients with Congenital Pseudarthrosis of the Tibia (CPT) using NVD003, an autologous therapy developed by Novadip for the reconstruction of bone tissue. CPT is a very

Novadip Biosciences, a late-stage clinical biotechnology company specializing in regenerative medicine, has announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to its tissue regeneration product, NVD003, for the treatment of congenital pseudarthosis of the tibia (CPT). The RMAT designation, issued to cell therapies, therapeutic tissue

Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, the “Company”), a clinical-stage biotech company developing oral therapies for autoimmune, inflammatory and neurodegenerative diseases, has announced positive top-line results from its Phase 2a study of VTX3232, a novel, CNS-penetrant NLRP3 inhibitor, in patients with early-stage Parkinson’s disease (NCT06556173). The study accomplished the primary

Resolve Therapeutics, a leader in the emerging field of cell-free nucleic acid therapeutics, has announced a collaboration with the Department of Surgery, Duke University School of Medicine to analyze the role of cell-free RNA (cfRNA) in polytrauma. A significant number of trauma patients admitted to the hospital each year suffer

Achronix Semiconductor Corporation, the leader in data acceleration FPGAs, has announced the launch of the VectorPath® 815 (VP815), a new PCIe accelerator card powered by the industry- leading Speedster® 7t1500 FPGA, and engineered to meet the growing demands of AI workloads and high-performance computing (HPC). FPGAs are uniquely suited for

Novadip Biosciences, a late-stage clinical biotechnology company specializing in regenerative medicine, has announced the five-year follow-up results from the Phase 1/2 clinical trial of its investigational tissue regeneration product, NVD003, in adult patients with severe bone non-union (BNU) of the lower limb, following trauma. The five-year safety and efficacy data

VUV Analytics, Inc., a global leader in vacuum ultraviolet (VUV) spectroscopy, is excited to introduce HYDRA, a breakthrough detector for Liquid Chromatography (LC). HYDRA makes advanced chemical analysis easier with universal detection, exceptional spectral selectivity, and seamless integration into lab workflows. “HYDRA is a major step forward for Liquid Chromatography

Novadip Biosciences, a late-stage clinical biotechnology company specializing in regenerative medicine, has announced the appointment of Soumya Chandramouli as Chief Financial Officer (CFO). Soumya Chandramouli has 25 years’ experience in financial management, most recently as Chief Financial Officer of IBA Group, a listed company in the medical device and healthcare

San José Connection Partners, a consortium including Plenary Americas, Webcor/Obayashi, and HNTB, and Glydways has announced that the San José City Council voted unanimously to move the Diridon–Airport Connector into Phase 2a of project development. The decision marks a significant step toward achieving the City’s sustainable mobility goals, reflecting strong

NorthSea Therapeutics B.V. (‘NST’, or the ‘Company’), a private, late-stage clinical biotechnology company developing novel strategies to treat metabolic, cholestatic, and fibrotic diseases, has announced that results from the Phase 2b ICONA clinical trial of icosabutate in biopsy-confirmed F1-F3 metabolic dysfunction-associated steatohepatitis (MASH) were published in the Journal of Hepatology.

Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases, has announced that data from the Phase 2 trial of its TYK2 inhibitor VTX958 in Crohn’s disease will be presented during the 20th Congress of

RANsemi, a British wireless semiconductor innovator specialising in 5G Open RAN baseband technologies, has partnered with Antevia Networks for its 5G SHIFT enterprise private 5G platform. 5G SHIFT employs Open RAN (O-RAN) fronthaul technology in its Radio Units (O-RUs) running on RANsemi 5G PHY SoCs to enhance in-building wireless coverage.

Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases, has highlighted its 2025 pipeline strategy and provided clinical updates on its NLRP3 inhibitor portfolio, including VTX2735 and VTX3232. “We believe that 2025 will be

Phase Four, a leader in advanced in-space propulsion design and manufacturing, has announced the first close of its Series C funding round, securing nearly 60% of the target raise with strong participation from new and existing investors. The round is led by Artemis Group Capital, the Oklahoma-based investment firm helmed

VORAGO Technologies, a leading provider of radiation hardened and radiation tolerant MCUs and MPUs for Aerospace and Defense, and Collabora, a leader in open source software and support, today announced they are partnering to advance the use of open source to achieve resilience for mission critical applications in space. “As